Subjects should be willing to sign an informed consent document and get finished with the parent study and be willing to stay on this study until their treatment is complete.
1. History of any other diseases, 2. Pregnant and nursing females.3. History of drug allergy in the parent study that would pose an additional risk to the subject in the opinion of the investigator. 4. Current participation in another research study using drugs